CHA₂DS₂-VASc score and prior oral anticoagulant use on endovascular treatment for acute ischemic stroke.

ABSTRACT:

Objective

We evaluated the effect of CHA₂DS₂-VASc score and prior use of oral anticoagulants (OACs) on endovascular treatment (EVT) in patients with acute ischemic stroke and atrial fibrillation (AF).

Methods

Patients with AF who received EVT in 353 centers in Japan (2018-2020) were included. The outcomes were symptomatic intracerebral hemorrhage (sICH), in-hospital mortality, functional independence, and successful and complete reperfusion. The effects of CHA₂DS₂-VASc score, its components, and prior use of OACs were assessed via a multiple logistic regression model.

Results

Of the 6984 patients, 780 (11.2%) used warfarin and 1168 (16.7%) used direct oral anticoagulants (DOACs) before EVT. Based on the CHA₂DS

SUBMITTER: Imaoka Y 

PROVIDER: S-EPMC11651198 | biostudies-literature | 2024 Dec

REPOSITORIES: biostudies-literature